Diabetic cardiomyopathy
View Full Paper
Ask AI
Bookmark
Share
Key result
The definition and existence of a distinct diabetic cardiomyopathy remain debated, with conflicting uses of the term to describe the effects of diabetes on the cardiovascular system.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
This review highlights the lack of a universally accepted definition for diabetic cardiomyopathy and proposes a new definition to guide future clinical and research efforts.
Key Points
- To review the historical background, clinical definitions, and diagnostic validity of diabetic cardiomyopathy as a distinct cardiac disorder.
- Narrative evaluation of historical literature, clinical trial evidence, and evolving diagnostic criteria for diabetes-related heart disease from 1876 to the present.
- Synthesis of cardiac outcomes related to pharmacotherapy, including thiazolidinediones and newer glucose-lowering drugs.
- The clinical designation of diabetic cardiomyopathy has increased substantially since 1972, though consensus remains lacking on whether it is an independent disease or reflects generalized vascular complications.
- Drug safety evaluations with thiazolidinediones and subsequent cardioprotective findings from newer antidiabetic agents have heightened clinical interest in defining distinct myocardial pathology.
PICO
P
Population
Diabetic cardiomyopathy
This review highlights the lack of a universally accepted definition for diabetic cardiomyopathy and proposes a new definition to guide future clinical and research efforts.
Cite This Study
Lee et al. (2018) conducted a review in Diabetic cardiomyopathy. The definition and existence of a distinct diabetic cardiomyopathy remain debated, with conflicting uses of the term to describe the effects of diabetes on the cardiovascular system.
Topics
View Full Paper
Ask AI
Bookmark
Share